Variability in Personal Non-Household Interactions: A Longitudinal Study from Germany, April 2020 to December 2021 - Takeaways - MDSpire

Variability in Personal Non-Household Interactions: A Longitudinal Study from Germany, April 2020 to December 2021

  • By

  • Chao Xu

  • Aleksandr Bryzgalov

  • Johannes Horn

  • Andrzej K. Jarynowski

  • Vitaly Belik

  • Veronika K Jaeger

  • André Karch

  • Huynh Thi Phuong

  • Janik Suer

  • Marlli Zambrano

  • Steven Schulz

  • Alejandra Rincón Hidalgo

  • Ashish Thampi

  • Richard Pastor

  • Rafael Mikolajczyk

  • February 21, 2026

  • 0 min

Share

  • 1

    The study analyzes variability in non-household contact rates during the COVID-19 pandemic in Germany from April 2020 to December 2021.

  • 2

    Individual contact behavior fluctuates due to stable characteristics and time-varying influences, impacting epidemic modeling accuracy.

  • 3

    The research utilizes a residual-based metric (riSD) to quantify within-individual variability in contact rates across different periods.

  • 4

    Findings indicate that sociodemographic factors and vaccination status influence individual variability in contact behavior.

  • 5

    The study highlights the importance of considering within-person variability to improve epidemic models and inform public health strategies.

Original Source(s)

Variability in Personal Non-Household Interactions: A Longitudinal Study from Germany, April 2020 to December 2021

  • by Chao Xu, Aleksandr Bryzgalov, Johannes Horn, Andrzej K. Jarynowski, Vitaly Belik, Veronika K Jaeger, André Karch, Huynh Thi Phuong, Janik Suer, Marlli Zambrano, Steven Schulz, Alejandra Rincón Hidalgo, Ashish Thampi, Richard Pastor, Rafael Mikolajczyk

  • February 21, 2026

Related Content

High-Dose vs Standard-Dose Influenza Vaccines in Older Adults: A Meta-Analysis

Multi-omics analysis of long COVID (post-COVID-19 condition) reveals persistent mitochondrial dysfunction, suppressed oxidative phosphorylation, and immune dysregulation

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.